Susan J Danis

Title: The Innovative Contributions of Susan J. Danis

Introduction

Susan J. Danis is a notable inventor based in Oakland, NJ (US). She has made significant contributions to the field of immunology through her innovative work in developing immunosuppressant agents. Her research has the potential to greatly impact organ transplant procedures and improve patient outcomes.

Latest Patents

Susan J. Danis holds a patent for the "Process for producing immunosuppressant agent L-683942 by fermentation." This patent describes a new method for producing the immunosuppressant L-683,742, which is a C-31 demethylated derivative of L-683,590 (FK-520). The process utilizes a mutant microorganism, Streptomyces hygroscopicus subsp. ascomyceticus, under fermentation conditions. This macrolide immunosuppressant is particularly useful in preventing human host rejection of foreign organ transplants, such as bone marrow and heart transplants.

Career Highlights

Susan is associated with Merck & Company, Inc., where she has been able to apply her expertise in microbiology and fermentation processes. Her work has contributed to advancements in the pharmaceutical industry, particularly in the development of drugs that aid in organ transplantation.

Collaborations

Throughout her career, Susan has collaborated with esteemed colleagues, including Carolyn L. Ruby and Byron H. Arison. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Susan J. Danis exemplifies the spirit of innovation in the field of immunology. Her contributions through her patent and work at Merck & Company, Inc. highlight the importance of research in improving medical treatments and patient care.